Evotec SE

NASDAQ:EVOUnited States

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Contact Information

Headquarters

Essener Bogen 7HAMBURG, Germany 22419

Phone

---

Fax

405-608-1222

Executives

Independent Chairwoman of the Supervisory Board

Iris Loew-Friedrich

Independent Vice Chairman of the Supervisory Board

Roland Sackers

Chief Financial Officer, Member of the Management Board

Laetitia Rouxel

Chief Operating Officer, Member of the Management Board

Craig Johnstone

Chief Scientific Officer, Member of the Management Board

Cord Dohrmann